![](/img/cover-not-exists.png)
An elevated fibrinogen/CRP ratio predicts a remarkable survival advantage in patients with metastatic pancreatic cancer
Winder, T., Posch, F., Asamer, E., Stotz, M., Siebenhüner, A., Schlick, K., Magnes, T., Samaras, P., Szkandera, J., Clavien, P-A., Neureiter, D., Greil, R., Pestalozzi, B.C., Stoeger, H., Gerger, A.,Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw371.77
Date:
October, 2016
File:
PDF, 38 KB
english, 2016